HEADER OXIDOREDUCTASE 27-JUN-19 6S4A TITLE STRUCTURE OF HUMAN MTHFD2 IN COMPLEX WITH TH9028 CAVEAT 6S4A KUK A 401 HAS WRONG CHIRALITY AT ATOM C06 KUK B 401 HAS CAVEAT 2 6S4A WRONG CHIRALITY AT ATOM C06 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL METHYLENETETRAHYDROFOLATE COMPND 3 DEHYDROGENASE/CYCLOHYDROLASE, MITOCHONDRIAL; COMPND 4 CHAIN: A, B; COMPND 5 EC: 1.5.1.15,3.5.4.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MTHFD2, NMDMC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR R.GUSTAFSSON,E.R.SCALETTI,N.BONAGAS,N.M.GUSTAFSSON,M.HENRIKSSON, AUTHOR 2 E.ABDURAKHMANOV,Y.ANDERSSON,C.BENGTSSON,S.BORHADE,M.DESROSES, AUTHOR 3 K.FARNEGARDH,N.GARG,C.GOKTURK,M.HARALDSSON,P.ILIEV,M.JARVIUS, AUTHOR 4 A.S.JEMTH,C.KALDEREN,S.KARSTEN,F.KLINGEGARD,T.KOOLMEISTER,U.MARTENS, AUTHOR 5 S.LLONA-MINGUEZ,O.LOSEVA,P.MARTTILA,M.MICHEL,R.MOULSON,H.NORDSTROM, AUTHOR 6 C.PAULIN,T.PHAM,L.PUDELKO,A.RASTI,A.K.ROOS,A.SARNO,L.SANDBERG, AUTHOR 7 M.SCOBIE,B.SJOBERG,R.SVENSSON,J.E.UNTERLASS,K.VALLIN,D.VO,E.WIITA, AUTHOR 8 U.WARPMAN-BERGLUND,E.J.HOMAN,T.HELLEDAY,P.STENMARK REVDAT 2 11-MAY-22 6S4A 1 JRNL REMARK REVDAT 1 07-JUL-21 6S4A 0 JRNL AUTH N.BONAGAS,N.M.S.GUSTAFSSON,M.HENRIKSSON,P.MARTTILA, JRNL AUTH 2 R.GUSTAFSSON,E.WIITA,S.BORHADE,A.C.GREEN,K.S.A.VALLIN, JRNL AUTH 3 A.SARNO,R.SVENSSON,C.GOKTURK,T.PHAM,A.S.JEMTH,O.LOSEVA, JRNL AUTH 4 V.COOKSON,N.KIWELER,L.SANDBERG,A.RASTI,J.E.UNTERLASS, JRNL AUTH 5 M.HARALDSSON,Y.ANDERSSON,E.R.SCALETTI,C.BENGTSSON, JRNL AUTH 6 C.B.J.PAULIN,K.SANJIV,E.ABDURAKHMANOV,L.PUDELKO,B.KUNZ, JRNL AUTH 7 M.DESROSES,P.ILIEV,K.FARNEGARDH,A.KRAMER,N.GARG,M.MICHEL, JRNL AUTH 8 S.HAGGBLAD,M.JARVIUS,C.KALDEREN,A.B.JENSEN,I.ALMLOF, JRNL AUTH 9 S.KARSTEN,S.M.ZHANG,M.HAGGBLAD,A.ERIKSSON,J.LIU, JRNL AUTH10 B.GLINGHAMMAR,N.NEKHOTIAEVA,F.KLINGEGARD,T.KOOLMEISTER, JRNL AUTH11 U.MARTENS,S.LLONA-MINGUEZ,R.MOULSON,H.NORDSTROM,V.PARROW, JRNL AUTH12 L.DAHLLUND,B.SJOBERG,I.L.VARGAS,D.D.VO,J.WANNBERG,S.KNAPP, JRNL AUTH13 H.E.KROKAN,P.I.ARVIDSSON,M.SCOBIE,J.MEISER,P.STENMARK, JRNL AUTH14 U.W.BERGLUND,E.J.HOMAN,T.HELLEDAY JRNL TITL PHARMACOLOGICAL TARGETING OF MTHFD2 SUPPRESSES ACUTE MYELOID JRNL TITL 2 LEUKEMIA BY INDUCING THYMIDINE DEPLETION AND REPLICATION JRNL TITL 3 STRESS. JRNL REF NAT CANCER V. 3 156 2022 JRNL REFN ESSN 2662-1347 JRNL PMID 35228749 JRNL DOI 10.1038/S43018-022-00331-Y REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 113.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 58965 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3073 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4297 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.76 REMARK 3 BIN R VALUE (WORKING SET) : 0.3660 REMARK 3 BIN FREE R VALUE SET COUNT : 247 REMARK 3 BIN FREE R VALUE : 0.3860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4483 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 240 REMARK 3 SOLVENT ATOMS : 229 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.74000 REMARK 3 B22 (A**2) : 1.74000 REMARK 3 B33 (A**2) : -5.65000 REMARK 3 B12 (A**2) : 0.87000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.120 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.122 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.112 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.283 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.976 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.965 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4866 ; 0.014 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4723 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6630 ; 1.809 ; 2.029 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10929 ; 1.000 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 595 ; 6.082 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 180 ;38.080 ;24.889 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 828 ;13.677 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;20.031 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 780 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5180 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 848 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2380 ; 3.818 ; 5.486 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2379 ; 3.816 ; 5.485 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2975 ; 5.106 ; 8.195 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2976 ; 5.105 ; 8.196 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2486 ; 5.771 ; 6.331 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2487 ; 5.770 ; 6.334 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3656 ; 8.222 ; 9.293 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5332 ;10.194 ;67.506 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5333 ;10.194 ;67.526 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6S4A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1292103107. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62083 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 49.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.20 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.8, 80 % V/V MPD, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.69933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.84967 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 56.77450 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 18.92483 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 94.62417 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -137.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 282 REMARK 465 VAL A 283 REMARK 465 ARG A 333 REMARK 465 LEU A 334 REMARK 465 GLU A 335 REMARK 465 GLU A 336 REMARK 465 ARG A 337 REMARK 465 GLU A 338 REMARK 465 VAL A 339 REMARK 465 LEU A 340 REMARK 465 LYS A 341 REMARK 465 SER A 342 REMARK 465 LYS A 343 REMARK 465 GLU A 344 REMARK 465 LEU A 345 REMARK 465 GLY A 346 REMARK 465 VAL A 347 REMARK 465 ALA A 348 REMARK 465 THR A 349 REMARK 465 ASN A 350 REMARK 465 VAL B 283 REMARK 465 THR B 284 REMARK 465 ALA B 285 REMARK 465 ARG B 333 REMARK 465 LEU B 334 REMARK 465 GLU B 335 REMARK 465 GLU B 336 REMARK 465 ARG B 337 REMARK 465 GLU B 338 REMARK 465 VAL B 339 REMARK 465 LEU B 340 REMARK 465 LYS B 341 REMARK 465 SER B 342 REMARK 465 LYS B 343 REMARK 465 GLU B 344 REMARK 465 LEU B 345 REMARK 465 GLY B 346 REMARK 465 VAL B 347 REMARK 465 ALA B 348 REMARK 465 THR B 349 REMARK 465 ASN B 350 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 205 -73.80 -135.67 REMARK 500 ALA A 253 45.66 -142.88 REMARK 500 GLU B 36 105.50 68.79 REMARK 500 VAL B 205 -77.19 -132.09 REMARK 500 VAL B 279 -168.84 -124.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KUK A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAD A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KUK B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 B 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAD B 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD B 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD B 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD B 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD B 409 DBREF 6S4A A 36 350 UNP P13995 MTDC_HUMAN 36 350 DBREF 6S4A B 36 350 UNP P13995 MTDC_HUMAN 36 350 SEQADV 6S4A MET A 35 UNP P13995 INITIATING METHIONINE SEQADV 6S4A MET B 35 UNP P13995 INITIATING METHIONINE SEQRES 1 A 316 MET GLU ALA VAL VAL ILE SER GLY ARG LYS LEU ALA GLN SEQRES 2 A 316 GLN ILE LYS GLN GLU VAL ARG GLN GLU VAL GLU GLU TRP SEQRES 3 A 316 VAL ALA SER GLY ASN LYS ARG PRO HIS LEU SER VAL ILE SEQRES 4 A 316 LEU VAL GLY GLU ASN PRO ALA SER HIS SER TYR VAL LEU SEQRES 5 A 316 ASN LYS THR ARG ALA ALA ALA VAL VAL GLY ILE ASN SER SEQRES 6 A 316 GLU THR ILE MET LYS PRO ALA SER ILE SER GLU GLU GLU SEQRES 7 A 316 LEU LEU ASN LEU ILE ASN LYS LEU ASN ASN ASP ASP ASN SEQRES 8 A 316 VAL ASP GLY LEU LEU VAL GLN LEU PRO LEU PRO GLU HIS SEQRES 9 A 316 ILE ASP GLU ARG ARG ILE CYS ASN ALA VAL SER PRO ASP SEQRES 10 A 316 LYS ASP VAL ASP GLY PHE HIS VAL ILE ASN VAL GLY ARG SEQRES 11 A 316 MET CYS LEU ASP GLN TYR SER MET LEU PRO ALA THR PRO SEQRES 12 A 316 TRP GLY VAL TRP GLU ILE ILE LYS ARG THR GLY ILE PRO SEQRES 13 A 316 THR LEU GLY LYS ASN VAL VAL VAL ALA GLY ARG SER LYS SEQRES 14 A 316 ASN VAL GLY MET PRO ILE ALA MET LEU LEU HIS THR ASP SEQRES 15 A 316 GLY ALA HIS GLU ARG PRO GLY GLY ASP ALA THR VAL THR SEQRES 16 A 316 ILE SER HIS ARG TYR THR PRO LYS GLU GLN LEU LYS LYS SEQRES 17 A 316 HIS THR ILE LEU ALA ASP ILE VAL ILE SER ALA ALA GLY SEQRES 18 A 316 ILE PRO ASN LEU ILE THR ALA ASP MET ILE LYS GLU GLY SEQRES 19 A 316 ALA ALA VAL ILE ASP VAL GLY ILE ASN ARG VAL HIS ASP SEQRES 20 A 316 PRO VAL THR ALA LYS PRO LYS LEU VAL GLY ASP VAL ASP SEQRES 21 A 316 PHE GLU GLY VAL ARG GLN LYS ALA GLY TYR ILE THR PRO SEQRES 22 A 316 VAL PRO GLY GLY VAL GLY PRO MET THR VAL ALA MET LEU SEQRES 23 A 316 MET LYS ASN THR ILE ILE ALA ALA LYS LYS VAL LEU ARG SEQRES 24 A 316 LEU GLU GLU ARG GLU VAL LEU LYS SER LYS GLU LEU GLY SEQRES 25 A 316 VAL ALA THR ASN SEQRES 1 B 316 MET GLU ALA VAL VAL ILE SER GLY ARG LYS LEU ALA GLN SEQRES 2 B 316 GLN ILE LYS GLN GLU VAL ARG GLN GLU VAL GLU GLU TRP SEQRES 3 B 316 VAL ALA SER GLY ASN LYS ARG PRO HIS LEU SER VAL ILE SEQRES 4 B 316 LEU VAL GLY GLU ASN PRO ALA SER HIS SER TYR VAL LEU SEQRES 5 B 316 ASN LYS THR ARG ALA ALA ALA VAL VAL GLY ILE ASN SER SEQRES 6 B 316 GLU THR ILE MET LYS PRO ALA SER ILE SER GLU GLU GLU SEQRES 7 B 316 LEU LEU ASN LEU ILE ASN LYS LEU ASN ASN ASP ASP ASN SEQRES 8 B 316 VAL ASP GLY LEU LEU VAL GLN LEU PRO LEU PRO GLU HIS SEQRES 9 B 316 ILE ASP GLU ARG ARG ILE CYS ASN ALA VAL SER PRO ASP SEQRES 10 B 316 LYS ASP VAL ASP GLY PHE HIS VAL ILE ASN VAL GLY ARG SEQRES 11 B 316 MET CYS LEU ASP GLN TYR SER MET LEU PRO ALA THR PRO SEQRES 12 B 316 TRP GLY VAL TRP GLU ILE ILE LYS ARG THR GLY ILE PRO SEQRES 13 B 316 THR LEU GLY LYS ASN VAL VAL VAL ALA GLY ARG SER LYS SEQRES 14 B 316 ASN VAL GLY MET PRO ILE ALA MET LEU LEU HIS THR ASP SEQRES 15 B 316 GLY ALA HIS GLU ARG PRO GLY GLY ASP ALA THR VAL THR SEQRES 16 B 316 ILE SER HIS ARG TYR THR PRO LYS GLU GLN LEU LYS LYS SEQRES 17 B 316 HIS THR ILE LEU ALA ASP ILE VAL ILE SER ALA ALA GLY SEQRES 18 B 316 ILE PRO ASN LEU ILE THR ALA ASP MET ILE LYS GLU GLY SEQRES 19 B 316 ALA ALA VAL ILE ASP VAL GLY ILE ASN ARG VAL HIS ASP SEQRES 20 B 316 PRO VAL THR ALA LYS PRO LYS LEU VAL GLY ASP VAL ASP SEQRES 21 B 316 PHE GLU GLY VAL ARG GLN LYS ALA GLY TYR ILE THR PRO SEQRES 22 B 316 VAL PRO GLY GLY VAL GLY PRO MET THR VAL ALA MET LEU SEQRES 23 B 316 MET LYS ASN THR ILE ILE ALA ALA LYS LYS VAL LEU ARG SEQRES 24 B 316 LEU GLU GLU ARG GLU VAL LEU LYS SER LYS GLU LEU GLY SEQRES 25 B 316 VAL ALA THR ASN HET KUK A 401 33 HET PO4 A 402 5 HET PO4 A 403 5 HET PO4 A 404 5 HET NAD A 405 44 HET MPD A 406 8 HET MPD A 407 8 HET MPD A 408 8 HET KUK B 401 33 HET PO4 B 402 5 HET PO4 B 403 5 HET PO4 B 404 5 HET NAD B 405 44 HET MPD B 406 8 HET MPD B 407 8 HET MPD B 408 8 HET MPD B 409 22 HETNAM KUK (2~{S})-2-[[5-[[2,4-BIS(AZANYL)-6-OXIDANYLIDENE-5~{H}- HETNAM 2 KUK PYRIMIDIN-5-YL]CARBAMOYLAMINO]PYRIDIN-2- HETNAM 3 KUK YL]CARBONYLAMINO]-4-(1~{H}-1,2,3,4-TETRAZOL-5-YL) HETNAM 4 KUK BUTANOIC ACID HETNAM PO4 PHOSPHATE ION HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETSYN KUK TH9028 FORMUL 3 KUK 2(C16 H18 N12 O5) FORMUL 4 PO4 6(O4 P 3-) FORMUL 7 NAD 2(C21 H27 N7 O14 P2) FORMUL 8 MPD 7(C6 H14 O2) FORMUL 20 HOH *229(H2 O) HELIX 1 AA1 SER A 41 SER A 63 1 23 HELIX 2 AA2 ASN A 78 GLY A 96 1 19 HELIX 3 AA3 SER A 109 ASN A 122 1 14 HELIX 4 AA4 ASP A 140 VAL A 148 1 9 HELIX 5 AA5 SER A 149 ASP A 153 5 5 HELIX 6 AA6 HIS A 158 LEU A 167 1 10 HELIX 7 AA7 PRO A 174 THR A 187 1 14 HELIX 8 AA8 VAL A 205 THR A 215 1 11 HELIX 9 AA9 PRO A 236 ILE A 245 1 10 HELIX 10 AB1 THR A 261 ILE A 265 5 5 HELIX 11 AB2 ASP A 294 ALA A 302 1 9 HELIX 12 AB3 GLY A 311 LYS A 329 1 19 HELIX 13 AB4 SER B 41 SER B 63 1 23 HELIX 14 AB5 ASN B 78 VAL B 95 1 18 HELIX 15 AB6 SER B 109 ASN B 122 1 14 HELIX 16 AB7 ASP B 140 VAL B 148 1 9 HELIX 17 AB8 SER B 149 ASP B 153 5 5 HELIX 18 AB9 HIS B 158 LEU B 167 1 10 HELIX 19 AC1 PRO B 174 THR B 187 1 14 HELIX 20 AC2 VAL B 205 THR B 215 1 11 HELIX 21 AC3 PRO B 236 ILE B 245 1 10 HELIX 22 AC4 THR B 261 ILE B 265 5 5 HELIX 23 AC5 ASP B 294 ALA B 302 1 9 HELIX 24 AC6 GLY B 311 LYS B 330 1 20 SHEET 1 AA112 VAL A 38 VAL A 39 0 SHEET 2 AA112 TYR A 304 ILE A 305 1 O ILE A 305 N VAL A 38 SHEET 3 AA112 ALA A 270 ASP A 273 1 N VAL A 271 O TYR A 304 SHEET 4 AA112 ILE A 249 SER A 252 1 N VAL A 250 O ILE A 272 SHEET 5 AA112 ASN A 195 ALA A 199 1 N VAL A 197 O ILE A 251 SHEET 6 AA112 THR A 227 SER A 231 1 O THR A 229 N VAL A 196 SHEET 7 AA112 THR B 227 SER B 231 -1 O VAL B 228 N ILE A 230 SHEET 8 AA112 ASN B 195 ALA B 199 1 N VAL B 196 O THR B 227 SHEET 9 AA112 ILE B 249 SER B 252 1 O ILE B 251 N VAL B 197 SHEET 10 AA112 ALA B 270 ASP B 273 1 O ILE B 272 N VAL B 250 SHEET 11 AA112 TYR B 304 ILE B 305 1 O TYR B 304 N VAL B 271 SHEET 12 AA112 VAL B 38 VAL B 39 1 N VAL B 38 O ILE B 305 SHEET 1 AA2 3 ASN A 98 LYS A 104 0 SHEET 2 AA2 3 HIS A 69 VAL A 75 1 N VAL A 72 O ILE A 102 SHEET 3 AA2 3 GLY A 128 VAL A 131 1 O GLY A 128 N SER A 71 SHEET 1 AA3 2 ASN A 277 HIS A 280 0 SHEET 2 AA3 2 PRO A 287 VAL A 290 -1 O VAL A 290 N ASN A 277 SHEET 1 AA4 3 ASN B 98 LYS B 104 0 SHEET 2 AA4 3 HIS B 69 VAL B 75 1 N VAL B 72 O ILE B 102 SHEET 3 AA4 3 GLY B 128 VAL B 131 1 O GLY B 128 N SER B 71 SHEET 1 AA5 2 ASN B 277 HIS B 280 0 SHEET 2 AA5 2 PRO B 287 VAL B 290 -1 O VAL B 290 N ASN B 277 CISPEP 1 LEU A 133 PRO A 134 0 4.96 CISPEP 2 VAL A 308 PRO A 309 0 -2.16 CISPEP 3 LEU B 133 PRO B 134 0 11.55 CISPEP 4 VAL B 308 PRO B 309 0 -2.40 SITE 1 AC1 22 TYR A 84 ASN A 87 LYS A 88 VAL A 131 SITE 2 AC1 22 GLN A 132 LEU A 133 ASP A 155 PHE A 157 SITE 3 AC1 22 ILE A 276 ARG A 278 LEU A 289 PRO A 309 SITE 4 AC1 22 GLY A 310 GLY A 313 PRO A 314 NAD A 405 SITE 5 AC1 22 HOH A 510 HOH A 537 HOH A 550 HOH A 556 SITE 6 AC1 22 HOH A 574 HOH A 595 SITE 1 AC2 8 ARG A 201 ARG A 233 NAD A 405 HOH A 515 SITE 2 AC2 8 HOH A 573 ASP B 216 HIS B 219 HOH B 552 SITE 1 AC3 3 GLU A 77 PRO A 79 MPD A 408 SITE 1 AC4 3 VAL A 38 VAL A 39 HOH A 517 SITE 1 AC5 22 GLY A 200 ARG A 201 SER A 202 VAL A 205 SITE 2 AC5 22 HIS A 232 ARG A 233 ALA A 253 ALA A 254 SITE 3 AC5 22 GLY A 255 ILE A 256 VAL A 274 ILE A 276 SITE 4 AC5 22 VAL A 312 GLY A 313 THR A 316 KUK A 401 SITE 5 AC5 22 PO4 A 402 HOH A 515 HOH A 537 HOH A 563 SITE 6 AC5 22 HOH A 580 HOH A 595 SITE 1 AC6 3 LEU A 167 HIS A 219 GLU A 220 SITE 1 AC7 3 TRP A 181 ARG A 221 PRO A 222 SITE 1 AC8 6 HIS A 82 MET A 103 PO4 A 403 HOH A 501 SITE 2 AC8 6 HIS B 82 PO4 B 403 SITE 1 AC9 20 TYR B 84 ASN B 87 LYS B 88 VAL B 131 SITE 2 AC9 20 GLN B 132 LEU B 133 ASP B 155 PHE B 157 SITE 3 AC9 20 ILE B 276 LEU B 289 PRO B 309 GLY B 310 SITE 4 AC9 20 GLY B 313 PRO B 314 NAD B 405 HOH B 526 SITE 5 AC9 20 HOH B 533 HOH B 544 HOH B 558 HOH B 560 SITE 1 AD1 8 ASP A 216 HIS A 219 ARG B 201 ARG B 233 SITE 2 AD1 8 NAD B 405 HOH B 527 HOH B 545 HOH B 567 SITE 1 AD2 2 MPD A 408 HIS B 82 SITE 1 AD3 4 HOH A 583 HIS B 158 VAL B 159 HOH B 559 SITE 1 AD4 20 THR B 176 ARG B 201 SER B 202 VAL B 205 SITE 2 AD4 20 HIS B 232 ARG B 233 ALA B 253 ALA B 254 SITE 3 AD4 20 ILE B 256 VAL B 274 ILE B 276 GLY B 313 SITE 4 AD4 20 THR B 316 KUK B 401 PO4 B 402 HOH B 513 SITE 5 AD4 20 HOH B 527 HOH B 542 HOH B 549 HOH B 571 SITE 1 AD5 6 SER B 171 LEU B 173 TRP B 178 ASN B 323 SITE 2 AD5 6 ILE B 326 MPD B 409 SITE 1 AD6 8 GLU A 100 ILE A 102 LEU A 116 LYS A 119 SITE 2 AD6 8 HOH A 584 GLU B 100 LYS B 119 LEU B 120 SITE 1 AD7 2 ARG B 54 ALA B 93 SITE 1 AD8 4 TRP B 181 ARG B 221 PRO B 222 MPD B 406 CRYST1 115.068 115.068 113.549 90.00 90.00 120.00 P 65 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008691 0.005017 0.000000 0.00000 SCALE2 0.000000 0.010035 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008807 0.00000